Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00448721
Status:
COMPLETED
Last Update Posted:
2018-03-01
First Post:
2007-03-15
Brief Title:
A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor TKI - Failure in Patients With Renal Cancer
Sponsor:
AEterna Zentaris
Organization:
AEterna Zentaris
Organization Data
Organization:
AEterna Zentaris
Class:
INDUSTRY
Study ID:
Perifosine 228
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
AEterna Zentaris
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Dana-Farber Cancer Institute | OTHER |